CPHI China was initiated as the showcase of APIs and has gradually developed into a large-scale comprehensive service platform connecting the entire pharmaceutical industry chain in Asian-Pacific region. For two decades, CPhI Shanghai has borne witness of the ever-reforming pharma industry, trailed every pace of growth and progress of the pharma manufacturers. 
 

On the morning of December 16th, our team arrived at our booth W4C02, and began to greet customers with their enthusiasm. 

 
Although countries around the world are still in the COVID-19 epidemic prevention and control period, due to the efforts of the government of China, the epidemic is under control in China, there are tens of thousands of customers poured into the exhibition.
 

 
On the first day, we greeted many new and old customers from different regions to negotiate business.

The products brochures displayed on the Huateng Pharma booth, bilingual multimedia promotional videos, and the enthusiastic explanations of our team attracted many visitors. Through careful communication with the visitors, each visitor had a deep understanding of Huateng Pharma’s products and services. 
 

 
On December 18th, the 20th CPHI Shanghai 2020 ended successfully at Shanghai New International Expo Centre (SNIEC). 

Huateng Pharma is a world leading supplier of PEG derivatives and a professional manufacturer of wide series of APIs, pharmaceutical intermediates and research chemicals. We have over 200 dedicated chemists and a 40000m2 GMP standard manufacturing base equipped with state-of-the-art facilities and management systems based on the general trend of intelligent manufacturing and environment friendly.